Reduction in the use of diagnostic tests in infants with risk factors for early-onset neonatal sepsis does not delay antibiotic treatment.


Autoria(s): Duvoisin, G.; Fischer, C.; Maucort-Boulch, D.; Giannoni, E.
Data(s)

2014

Resumo

Despite a low positive predictive value, diagnostic tests such as complete blood count (CBC) and C-reactive protein (CRP) are commonly used to evaluate whether infants with risk factors for early-onset neonatal sepsis (EOS) should be treated with antibiotics. We investigated the impact of implementing a protocol aiming at reducing the number of diagnostic tests in infants with risk factors for EOS in order to compare the diagnostic performance of repeated clinical examination with CBC and CRP measurement. The primary outcome was the time between birth and the first dose of antibiotics in infants treated for suspected EOS. Among the 11,503 infants born at ≥35 weeks during the study period, 222 were treated with antibiotics for suspected EOS. The proportion of infants receiving antibiotics for suspected EOS was 2.1% and 1.7% before and after the change of protocol (p = 0.09). Reduction of diagnostic tests was associated with earlier antibiotic treatment in infants treated for suspected EOS (hazard ratio 1.58; 95% confidence interval [CI] 1.20-2.07; p <0.001), and in infants with neonatal infection (hazard ratio 2.20; 95% CI 1.19-4.06; p = 0.01). There was no difference in the duration of hospital stay nor in the proportion of infants requiring respiratory or cardiovascular support before and after the change of protocol. Reduction of diagnostic tests such as CBC and CRP does not delay initiation of antibiotic treatment in infants with suspected EOS. The importance of clinical examination in infants with risk factors for EOS should be emphasised.

Identificador

https://serval.unil.ch/notice/serval:BIB_E795F198DFCD

info:pmid:24964177

https://serval.unil.ch/resource/serval:BIB_E795F198DFCD.P001/REF

http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_E795F198DFCD9

urn:nbn:ch:serval-BIB_E795F198DFCD9

Idioma(s)

eng

Fonte

Swiss medical weekly144w13981

Tipo

info:eu-repo/semantics/article

article

Formato

application/pdf

Direitos

info:eu-repo/semantics/openAccess

Copying allowed only for non-profit organizations

https://serval.unil.ch/disclaimer

Palavras-Chave #Anti-Bacterial Agents/therapeutic use; Bacterial Infections/blood; Bacterial Infections/diagnosis; Bacterial Infections/drug therapy; Blood Cell Count/utilization; C-Reactive Protein/metabolism; Diagnostic Tests, Routine/utilization; Female; Humans; Infant, Newborn; Length of Stay/statistics & numerical data; Male; Respiration, Artificial/statistics & numerical data; Risk Factors; Sepsis/blood; Sepsis/diagnosis; Sepsis/drug therapy; Time-to-Treatment